NuView Life Sciences is a clinical-stage precision oncology company.
The Vasoactive Intestinal Peptide/Pituitary Adenylate Cyclase-activating Peptide Receptor is over-expressed on the surface of a wide range of cancer types at the onset of oncogenesis.
NuView’s NV-VPAC1 small molecule binding agent designed to identify and bind to the VPAC receptors has been utilized in clinical trials for binary in vitro and in vivo confirmation of cancer.
The NV-VPAC1 agent can deliver existing therapeutics and new alpha and beta emitters.
NuView will pair existing imaging and therapeutic radionuclides with NuViews proprietary agent and provide a Theranostics solution for patients and clinicians.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 1389 Center Drive, Suite 200, Park City,utah 84098,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- nuviewinfo.com
- Keywords
- Molecular Imaging Diagnostics, Molecular In Vitro Diagnostics, Oncology, Urine Screen for Prostate Cancer, Urine Screen for Bladder Cancer, Breast Cancer Imaging, Prostate Cancer Imaging, In Vitro Prostate Cancer Test, Prostate Cancer.
- HQ
- Park City, Utah
Nuview Life Sciences, Inc Questions
Nuview Life Sciences, Inc's website is nuviewinfo.com
Nuview Life Sciences, Inc's LinkedIn profile is https://www.linkedin.com/company/nuview-life-sciences-inc
Nuview Life Sciences, Inc has
5 employees.
View email and phone details for 5
employees at Nuview Life Sciences, Inc.
Nuview Life Sciences, Inc's industry is
Biotechnology Research
Nuview Life Sciences, Inc's top competitors are
Imaginab,
Radiopharm Theranostics,
Precirix,
Lantheus,
Entero Therapeutics (Nasdaq: Ento),
Corvidane,
Relmada Therapeutics, Inc,
Cellectar Biosciences, Inc.,
Applied Therapeutics, Inc.,
Iotron Medical.
Nuview Life Sciences, Inc's categories are Biotechnology Research
Nuview Life Sciences, Inc's founding year is 2006
